Calliditas Therapeutics AB (publ)
CLTEF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $0 | $21 | $797 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $272 | $223 |
| Inventory | $0 | $0 | $0 | $40 |
| Other Curr. Assets | $0 | $0 | -$272 | $94 |
| Total Curr. Assets | $1 | $0 | $0 | $1,154 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $59 |
| Goodwill | $0 | $0 | $8,134 | $48 |
| Intangibles | $3 | $3 | $556 | $424 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$8,689 | $62 |
| Total NC Assets | $3 | $3 | $1 | $593 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3 | $3 | $1 | $1,747 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $151 |
| Short-Term Debt | $0 | $0 | $1,055 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | -$1,055 | $279 |
| Total Curr. Liab. | $0 | $0 | $0 | $430 |
| LT Debt | $0 | $0 | $0 | $1,008 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $202 |
| Total NC Liab. | $0 | $0 | $0 | $1,211 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $26 |
| Total Liabilities | $0 | $0 | $0 | $1,640 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $2 | $1 | $2 |
| Retained Earnings | -$0 | -$0 | -$0 | $0 |
| AOCI | $0 | $1 | $0 | $104 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $3 | $3 | $1 | $107 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3 | $3 | $8,983 | $1,747 |
| Net Debt | -$1 | $0 | $1,034 | $211 |